210 related articles for article (PubMed ID: 8727369)
1. [Genetic diagnosis of colorectal cancer].
Itoh F; Imai K
Hokkaido Igaku Zasshi; 1996 Jan; 71(1):9-14. PubMed ID: 8727369
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms.
Shattuck-Brandt RL; Lamps LW; Heppner Goss KJ; DuBois RN; Matrisian LM
Mol Carcinog; 1999 Mar; 24(3):177-87. PubMed ID: 10204802
[TBL] [Abstract][Full Text] [Related]
3. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
Horiuchi S; Yamamoto H; Min Y; Adachi Y; Itoh F; Imai K
J Pathol; 2003 Aug; 200(5):568-76. PubMed ID: 12898592
[TBL] [Abstract][Full Text] [Related]
4. Matrix-degrading metalloproteinases in tumor progression.
Matrisian LM; Wright J; Newell K; Witty JP
Princess Takamatsu Symp; 1994; 24():152-61. PubMed ID: 8983072
[TBL] [Abstract][Full Text] [Related]
5. [beta-Catenin induces invasive growth by activating matrix metalloproteinases in colorectal carcinoma].
Brabletz T; Jung A; Dag S; Reu S; Kirchner T
Verh Dtsch Ges Pathol; 2000; 84():175-81. PubMed ID: 11217438
[TBL] [Abstract][Full Text] [Related]
6. Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer.
Yamamoto H; Iku S; Adachi Y; Imsumran A; Taniguchi H; Nosho K; Min Y; Horiuchi S; Yoshida M; Itoh F; Imai K
J Pathol; 2003 Feb; 199(2):176-84. PubMed ID: 12533830
[TBL] [Abstract][Full Text] [Related]
7. Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice.
Powell WC; Knox JD; Navre M; Grogan TM; Kittelson J; Nagle RB; Bowden GT
Cancer Res; 1993 Jan; 53(2):417-22. PubMed ID: 8417833
[TBL] [Abstract][Full Text] [Related]
8. Enhanced secretion and activation of matrilysin during malignant conversion of human colorectal epithelium and its relationship with invasive potential of colon cancer cells.
Itoh F; Yamamoto H; Hinoda Y; Imai K
Cancer; 1996 Apr; 77(8 Suppl):1717-21. PubMed ID: 8608568
[TBL] [Abstract][Full Text] [Related]
9. Aberration of p53 and DCC in gastric and colorectal cancer.
Kataoka M; Okabayashi T; Johira H; Nakatani S; Nakashima A; Takeda A; Nishizaki M; Orita K; Tanaka N
Oncol Rep; 2000; 7(1):99-103. PubMed ID: 10601600
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of matrilysin antisense oligonucleotides on human colon cancer cell invasion in vitro.
Momiyama N; Koshikawa N; Ishikawa T; Ichikawa Y; Hasegawa S; Nagashima Y; Mitsuhashi M; Miyazaki K; Shimada H
Mol Carcinog; 1998 May; 22(1):57-63. PubMed ID: 9609101
[TBL] [Abstract][Full Text] [Related]
11. The deleted in colon cancer (DCC) gene is consistently expressed in colorectal cancers and metastases.
Gotley DC; Reeder JA; Fawcett J; Walsh MD; Bates P; Simmons DL; Antalis TM
Oncogene; 1996 Aug; 13(4):787-95. PubMed ID: 8761300
[TBL] [Abstract][Full Text] [Related]
12. DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination.
Tarafa G; Villanueva A; Farré L; Rodríguez J; Musulén E; Reyes G; Seminago R; Olmedo E; Paules AB; Peinado MA; Bachs O; Capellá G
Oncogene; 2000 Jan; 19(4):546-55. PubMed ID: 10698524
[TBL] [Abstract][Full Text] [Related]
13. Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo.
Witty JP; McDonnell S; Newell KJ; Cannon P; Navre M; Tressler RJ; Matrisian LM
Cancer Res; 1994 Sep; 54(17):4805-12. PubMed ID: 8062282
[TBL] [Abstract][Full Text] [Related]
14. The deleted in colorectal cancer (DCC) gene: a candidate tumour suppressor gene encoding a cell surface protein with similarity to neural cell adhesion molecules.
Fearon ER; Pierceall WE
Cancer Surv; 1995; 24():3-17. PubMed ID: 7553661
[TBL] [Abstract][Full Text] [Related]
15. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of APC promoter methylation and protein expression in colorectal cancer metastasis.
Chen J; Röcken C; Lofton-Day C; Schulz HU; Müller O; Kutzner N; Malfertheiner P; Ebert MP
Carcinogenesis; 2005 Jan; 26(1):37-43. PubMed ID: 15375009
[TBL] [Abstract][Full Text] [Related]
17. Expression of ets-related transcriptional factor E1AF is associated with tumor progression and over-expression of matrilysin in human gastric cancer.
Yamamoto H; Horiuchi S; Adachi Y; Taniguchi H; Nosho K; Min Y; Imai K
Carcinogenesis; 2004 Mar; 25(3):325-32. PubMed ID: 14604892
[TBL] [Abstract][Full Text] [Related]
18. [Molecular genetics of colorectal cancer and carcinogenesis].
Panduro Cerda A; Lima González G; Villalobos JJ
Rev Invest Clin; 1993; 45(5):493-504. PubMed ID: 8134731
[TBL] [Abstract][Full Text] [Related]
19. Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas.
Masaki T; Matsuoka H; Sugiyama M; Abe N; Goto A; Sakamoto A; Atomi Y
Br J Cancer; 2001 May; 84(10):1317-21. PubMed ID: 11355941
[TBL] [Abstract][Full Text] [Related]
20. Application of cycling gradient capillary electrophoresis to detection of APC, K-ras, and DCC point mutations in patients with sporadic colorectal tumors.
Minarik M; Minarikova L; Hrabikova M; Minarikova P; Hrabal P; Zavoral M
Electrophoresis; 2004 Apr; 25(7-8):1016-21. PubMed ID: 15095442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
